Filing Flows

Filing Flows › Dare Bioscience (DARE) › Next earnings date

Dare Bioscience (DARE) earnings on Nov 12, 2026: what to expect

Dare Bioscience (DARE) is expected to report earnings on Nov 12, 2026 (estimated), in 4 days, for the quarter ending Sep 30, 2026. Analysts expect EPS of −$0.13 (−$0.27 to $0.10, 3 estimates) on revenue of $2.0M, against −$0.28 and $2K a year ago. It beat the EPS estimate in 100% of the quarters on record; Filing Flows' model gives it a 86% chance of beating next time.

Report dateNov 12, 2026 (estimated)
Days to go4
EPS estimate−$0.13
Revenue estimate$2.0M
Beat rate100%

The last report

Dare Bioscience reported revenue of $188K for the second quarter 2026, net loss $3.0M. How it makes money → · Every quarter →

Dare Bioscience: EPS against the estimate, last 4 reportsDare Bioscience: EPS against the estimate, last 4 reportsEstimateReported−$0.40−$0.28Nov 25−$0.42−$0.10Mar 26−$0.30−$0.20May 26−$0.30−$0.20Aug 26
Latest (Aug 26): Estimate −$0.30, Reported −$0.20.

Dare Bioscience's latest quarter

Dare Bioscience, Q2 2026: revenue $188K, net loss $3.0M, operating cash flow −$6.8M. The chart follows the revenue to costs, profit and cash.

Questions

When does DARE report earnings?

Dare Bioscience is expected to report on Nov 12, 2026 (estimated).

What are analysts expecting from Dare Bioscience?

EPS of −$0.13 and revenue of $2.0M for the quarter.

Does Dare Bioscience usually beat earnings?

It beat the consensus EPS estimate in 100% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.